Login
tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals
tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals
tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals
 Next

tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals

Marsoni M251S
Sale price$29.61
Pay 4 payments of $7.40 a month.Shop Pay
Get it in 3 business days with 1 day shipping. Friday, May 29
Does Retatrutide Cause Hair Loss? Side Effects Explained Tirzepatide and B12 : r tirzepatidecompound Flexible Klarna Payment Plans For Weight Loss Memberships with Ivm Health What to Expect on Tirzepatide: Month by Month Weight Loss Timeline Can Medicare or Medicaid Pay for Bariatric Surgery? Costs & Coverage Breakdown
Easy Shipping

Quick Dispatch:

Your tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals orders ship within 1-2 business days.

Delivery Options:

  • Standard: 3-7 business days
  • Fast: 2-3 business days
  • Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals ships.

Need Help?
Questions about tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide idiopathic intracranial hypertension Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals in your area.

Get Shipping Estimates

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
4.3 ★★★★★
Based on 188 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
D
Verified Purchase
David
Louisville, US
★★★★★ 4
Important to Know
Format: Paperback
I very much like this study guide. It has helped me study for my exams. Some of my test questions have even come straight from this book. HOWEVER, I do caution anyone who buys this book to double check the answers. I have come across MULTIPLE typos and incorrect answers in the Answer Key. I like the content of this book, but for a professionally printed book, the overall completeness is poor.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 26, 2019
N
Verified Purchase
NicNac
Bozeman, US
★★★★★ 5
Great purchase
Format: Paperback
This was a great addition to the textbook. The textbook was awful in my opinion but this study guide really explained it in a easy to understand and direct way. I love the matching, fill in the blank and most importantly the case studies. Really helps you figure out what you may encounter pathophysiology wise when caring for patients.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 12, 2021
S
Verified Purchase
Samantha
Bozeman, US
★★★★★ 5
Definitely worth it
Format: Paperback
Cannot recommend this enough. It really cements the material from the book. If you use this, you will understand the content in the book. I find it incredibly helpful in my program.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 18, 2021
A
Verified Purchase
Amazon Customer
Dallas, US
★★★★★ 5
Watson's Caring Science is Cutting Edge!
Format: Paperback
Watson's Caring Science is Cutting Edge! You will begin seeing Watson's Caring Science infused in many organizational structures. Ride the wave you won't regret!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 9, 2023
V
Verified Purchase
very fun
Draper, US
★★★★★ 5
Great
Format: Paperback
I REALLY like this book. I’m new to online teaching and it has lots of good information and tips
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 9, 2020

recommand products

A growing number of Americans are using GLP-1 medications to aid in weight loss. A recent Gallup poll shows that 12% of adults were using GLP-1 medications during Q2 and Q3 of
A growing number of Americans are using GLP-1 medications to aid in weight loss. A recent Gallup poll shows that 12% of adults were using GLP-1 medications during Q2 and Q3 of
25.23
 Chart: 1 in 8 Americans Now Use GLP-1 Drugs for Weight Loss
Chart: 1 in 8 Americans Now Use GLP-1 Drugs for Weight Loss
23.50
 Nearly 12% of Americans have used GLP-1 drugs—such as Ozempic—for weight loss. 14% say they're interested in them. New findings from the largest and most recent survey on Americans' use of a
Nearly 12% of Americans have used GLP-1 drugs—such as Ozempic—for weight loss. 14% say they're interested in them. New findings from the largest and most recent survey on Americans' use of a
21.19
 Nearly 12% of Americans have used GLP-1 weight loss drugs
Nearly 12% of Americans have used GLP-1 weight loss drugs
24.28
 GLP-1 in NYC Is Not Correlated with Clinical Indication
GLP-1 in NYC Is Not Correlated with Clinical Indication
27.30